BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 8691128)

  • 1. Partial signaling by CD8+ T cells in response to antagonist ligands.
    Reis e Sousa C; Levine EH; Germain RN
    J Exp Med; 1996 Jul; 184(1):149-57. PubMed ID: 8691128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The efficiency of CD4 recruitment to ligand-engaged TCR controls the agonist/partial agonist properties of peptide-MHC molecule ligands.
    Madrenas J; Chau LA; Smith J; Bluestone JA; Germain RN
    J Exp Med; 1997 Jan; 185(2):219-29. PubMed ID: 9016871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered peptide ligands induce quantitatively but not qualitatively different intracellular signals in primary thymocytes.
    Smyth LA; Williams O; Huby RD; Norton T; Acuto O; Ley SC; Kioussis D
    Proc Natl Acad Sci U S A; 1998 Jul; 95(14):8193-8. PubMed ID: 9653163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ex vivo evidence for asymmetric tyrosine phosphorylation of ZAP-70 on double-positive thymocytes in the positive selection process.
    Kametani Y; Goto H; Kobori A; Sato T; Ando K; Hozumi K; Nishimura T; Saito T; Yamamoto T; Habu S
    Int Immunol; 1998 Aug; 10(8):1203-10. PubMed ID: 9723707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dissociation of intracellular signaling pathways in response to partial agonist ligands of the T cell receptor.
    Chau LA; Bluestone JA; Madrenas J
    J Exp Med; 1998 May; 187(10):1699-709. PubMed ID: 9584148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early molecular events induced by T cell receptor (TCR) signaling in immature CD4+ CD8+ thymocytes: increased synthesis of TCR-alpha protein is an early response to TCR signaling that compensates for TCR-alpha instability, improves TCR assembly, and parallels other indicators of positive selection.
    Kearse KP; Takahama Y; Punt JA; Sharrow SO; Singer A
    J Exp Med; 1995 Jan; 181(1):193-202. PubMed ID: 7528767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant TCR ligand induces early TCR signaling and a unique pattern of downstream activation.
    Wang C; Mooney JL; Meza-Romero R; Chou YK; Huan J; Vandenbark AA; Offner H; Burrows GG
    J Immunol; 2003 Aug; 171(4):1934-40. PubMed ID: 12902496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential T cell signaling induced by antagonist peptide-MHC complexes and the associated phenotypic responses.
    La Face DM; Couture C; Anderson K; Shih G; Alexander J; Sette A; Mustelin T; Altman A; Grey HM
    J Immunol; 1997 Mar; 158(5):2057-64. PubMed ID: 9036949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peptide-major histocompatibility complex class II complexes with mixed agonist/antagonist properties provide evidence for ligand-related differences in T cell receptor-dependent intracellular signaling.
    Racioppi L; Ronchese F; Matis LA; Germain RN
    J Exp Med; 1993 Apr; 177(4):1047-60. PubMed ID: 8384651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serial TCR engagement and down-modulation by peptide:MHC molecule ligands: relationship to the quality of individual TCR signaling events.
    Itoh Y; Hemmer B; Martin R; Germain RN
    J Immunol; 1999 Feb; 162(4):2073-80. PubMed ID: 9973480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD4 and CD8 are positive regulators of T cell receptor signal transduction in early T cell differentiation.
    Gilliland LK; Teh HS; Uckun FM; Norris NA; Teh SJ; Schieven GL; Ledbetter JA
    J Immunol; 1991 Mar; 146(6):1759-65. PubMed ID: 1706380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The quantity of TCR signal determines positive selection and lineage commitment of T cells.
    Watanabe N; Arase H; Onodera M; Ohashi PS; Saito T
    J Immunol; 2000 Dec; 165(11):6252-61. PubMed ID: 11086060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Entry of CD4-CD8- immature thymocytes into the CD4/CD8 developmental pathway is controlled by tyrosine kinase signals that can be provided through TCR components.
    Takahama Y; Hasegawa T; Itohara S; Ball EL; Sheard MA; Hashimoto Y
    Int Immunol; 1994 Oct; 6(10):1505-14. PubMed ID: 7826942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Zeta phosphorylation without ZAP-70 activation induced by TCR antagonists or partial agonists.
    Madrenas J; Wange RL; Wang JL; Isakov N; Samelson LE; Germain RN
    Science; 1995 Jan; 267(5197):515-8. PubMed ID: 7824949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Major histocompatibility complex class I molecules modulate activation threshold and early signaling of T cell antigen receptor-gamma/delta stimulated by nonpeptidic ligands.
    Carena I; Shamshiev A; Donda A; Colonna M; Libero GD
    J Exp Med; 1997 Nov; 186(10):1769-74. PubMed ID: 9362537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ZAP-70 binding specificity to T cell receptor tyrosine-based activation motifs: the tandem SH2 domains of ZAP-70 bind distinct tyrosine-based activation motifs with varying affinity.
    Isakov N; Wange RL; Burgess WH; Watts JD; Aebersold R; Samelson LE
    J Exp Med; 1995 Jan; 181(1):375-80. PubMed ID: 7528772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective induction of apoptosis in mature T lymphocytes by variant T cell receptor ligands.
    Combadière B; Reis e Sousa C; Germain RN; Lenardo MJ
    J Exp Med; 1998 Feb; 187(3):349-55. PubMed ID: 9449715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opposite ability of pre-TCR and alpha beta TCR to induce apoptosis.
    Steff AM; Trop S; Maira M; Drouin J; Hugo P
    J Immunol; 2001 Apr; 166(8):5044-50. PubMed ID: 11290785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T cell receptor- and beta 1 integrin-mediated signals synergize to induce tyrosine phosphorylation of focal adhesion kinase (pp125FAK) in human T cells.
    Maguire JE; Danahey KM; Burkly LC; van Seventer GA
    J Exp Med; 1995 Dec; 182(6):2079-90. PubMed ID: 7500053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Co-receptor-independent signal transduction in a mismatched CD8+ major histocompatibility complex class II-specific allogeneic cytotoxic T lymphocyte.
    Eshima K; Tachibana M; Suzuki H; Yamazaki S; Shinohara N
    Eur J Immunol; 1997 Jan; 27(1):55-61. PubMed ID: 9021998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.